RT Journal Article
T1 Hospital Management and Ambulatory Patient Care After COVID-19 Infection in Kidney Transplant.
A1 Teran-Redondo, Magdalena
A1 Muñoz-Martinez, Claudia
A1 Rosa-Guerrero, Pedro
A1 Aguera-Morales, M Luisa
A1 Torres-De-Rueda, Alvaro
A1 Rodriguez-Benot, Alberto
K1 Ambulatory Care
K1 COVID-19
K1 Hospitals
K1 Immunosuppressive Agents
AB A large number of registries have been collected for kidney transplant recipients infected with COVID-19. From March 2020 to April 2021, our team conducted an observational study, which included all patients who showed a polymerase chain reaction positive for COVID-19. Patients were divided into 2 groups: patients who required ambulatory care and patients who needed hospital admission. A total of 76 kidney transplant recipients were infected with COVID-19. A total of 33% required hospital admission and 65% received ambulatory treatment; 28% of our patients were asymptomatic and 6.8% died. Immunosuppressive treatment was modified in both study groups, and there were not any acute rejection episodes or changes in the human leukocyte antigen antibodies profile in our patients during our clinical trial. In our study there was a significant percentage of patients who did not require hospital admission compared with other studies. In addition, we think that the reduction of immunosuppression can be a safe and reliable treatment.
PB Elsevier
YR 2022
FD 2022-02-02
LK http://hdl.handle.net/10668/22532
UL http://hdl.handle.net/10668/22532
LA en
NO Redondo MT, Martínez CM, Guerrero PR, Morales MLA, De Rueda ÁT, Benot AR. Hospital Management and Ambulatory Patient Care After COVID-19 Infection in Kidney Transplant. Transplant Proc. 2022 Jan-Feb;54(1):22-24
DS RISalud
RD Sep 13, 2025